Symphogen to Report Preliminary Safety Data from a Phase 1 Study of Sym004

News   May 30, 2014

 
Symphogen to Report Preliminary Safety Data from a Phase 1 Study of Sym004
 
 
 

RELATED ARTICLES

Multidisciplinary Study Suggests New Strategy for Drug Discovery

News

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results, , suggest a new strategy for drug discovery.

READ MORE

Cold and Flu Season is Well Under Way But Don't Stifle a Sneeze Warn Doctors

News

Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors. One young man managed to rupture the back of his throat during this manoeuvre, leaving him barely able to speak or swallow, and in considerable pain.

READ MORE

Immunosuppressive Cells in Newborns Play Important Role in Controlling Inflammation in Early Life

News

New research has characterized the transitory presence of myeloid-derived suppressor cells (MDSCs) in mouse and human newborns, revealing a critical role of these cells in regulation of inflammation in the early stages of life.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE